John Lynch

Professor John Lynch is applying his expertise to address challenges in the field of pulmonary medicine at Washington University School of Medicine. With a focus on lung transplantation, pulmonary disease, pulmonary hypertension, and pulmonary fibrosis, his work is pivotal in advancing understanding and treatment in these critical areas. His clinical interests are closely aligned with his research pursuits, ensuring a comprehensive approach to patient care and scientific inquiry. Throughout his career, Professor Lynch has contributed significantly to the body of knowledge in his field. His publication, "Unintended consequences of changes to lung allocation policy," explores the impacts of policy shifts on patient outcomes, reflecting his commitment to improving healthcare systems. Another notable work, "How changes in Washington University's Medicare Coordinated Care Demonstration Pilot ultimately achieved savings," highlights his interest in healthcare efficiency and cost-effectiveness. In addition to his policy-focused research, Professor Lynch has made strides in clinical trials, as evidenced by his study, "A Randomized Controlled Trial of Tacrolimus Versus Cyclosporine After Lung Transplantation." This research underscores his dedication to optimizing post-transplant care and improving long-term outcomes for patients. Through his scholarly contributions and clinical expertise, Professor Lynch continues to influence the field of pulmonary medicine, striving to enhance both patient care and medical knowledge.